Rocapine

RocapineRocapine
Rocapine

Rocapine

AI-native wellness venture studio developing wellness apps designed to 'hold instead of hook'.

DR 372024Active15Paris, France
Rate

About

Rocapine is a Paris-based AI-native wellness venture studio that develops wellness applications. They operate on a high-velocity publisher model, testing hundreds of app concepts per year and partnering with independent developers. When a concept resonates, they craft personalized wellness apps and scale them quickly using their AI-native tech stack. Their focus is on creating apps that deliver real value and support users' daily routines, rather than engineering compulsion and monetizing attention. They aim to optimize for 'time well spent' rather than time-on-screen.
Frequently asked

What does Rocapine do?

Rocapine is a Paris-based AI-native wellness venture studio that develops wellness applications. They operate on a high-velocity publisher model, testing hundreds of app concepts per year and partnering with independent developers. When a concept resonates, they craft personalized wellness apps and scale them quickly using their AI-native tech stack. Their focus is on creating apps that deliver real value and support users' daily routines, rather than engineering compulsion and monetizing attent…

What is Rocapine's valuation?

StartupHub estimates Rocapine's effective valuation at $52.8M (range $32.5M to $78.0M, 21% confidence), based on comparable companies in the sector.

How much funding has Rocapine raised?

Rocapine has raised a total of $13M in funding. The most recent round on record is Series A.

Where is Rocapine headquartered?

Rocapine is headquartered in Paris, France.

When was Rocapine founded?

Rocapine was founded in 2024.

What industry does Rocapine operate in?

Rocapine operates in Health, Wellness, Mobile Apps, Artificial Intelligence.

How many employees does Rocapine have?

Rocapine has approximately 15 people on record.

HEADCOUNT
15
DOMAIN RATING
37
Comments

No comments yet. Be the first to share your take.